Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Sanofi and GlaxoSmithKLine COVID-19 Vaccines are Advancing in Clinical Trial

September 3, 2020 0

Sanofi and GlaxoSmithKline Have COVID-19 Vaccines Advancing in Clinical Trial Sanofi (SNY) and GlaxoSmithKline (GSK) started …

The U.S. CDC Tells the 50 States to Prepare for COVID-19 Vaccines by the End of October

September 3, 2020 0

CDC Is Asking States to Prepare for COVID-19 Vaccines The U.S. Center of Disease Control and …

Agenus: Could It Be a Resurrection? See Also: Prohost Performing Stocks

September 2, 2020 0

Agenus Announced Data from Phase 2 Trials of Balstilimab Agenus (AGEN) immuno-oncology company announced that data …

Moderna Inc Stock is Tanking After Rallying

September 1, 2020 0

Moderna Inc Late August Announcements On August 28, 2020 Moderna Inc (MRNA) issued a press release …

Why The Time Has Come for Rhythm Pharmaceuticals to Outperform

August 28, 2020 0

Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals (RYTM) is a late-stage biopharmaceutical company with a product pipeline that …

Moderna Encouraging News. See Also: Translate Bio and Sanofi Good News

August 27, 2020 0

Moderna Presented Interim Clinical Data about mRNA-1273 for COVID-19 Moderna (MRNA) presented new Interim Clinical Data …

Exelixis Announces Submission of sNDA to U.S. FDA for Cabozantinib in Combination with Nivolumab for Advanced RCC

August 25, 2020 0

Exelixis Announces Submission of sNDA to US FDA for CABOMETYX® Exelixis (EXEL) announced the submission of …

Kazia Therapeutics Product Paxalisib Beats Temozolomide in Overall Survival in Mid-Phase Trial

August 25, 2020 0

The US FDA Awards Fast Track Designation to Paxalisib for Glioblastoma Kazia Therapeutics Ltd (KZIA) – an …

What’s Going on with Gene Therapy?

August 25, 2020 0

Recent Gene Therapy News On August 20, 2020 Audentes Therapeutics, which was taken over by Astellas …

The FDA’s Complete Response Letters, Creating Investment Opportunities?

August 20, 2020 0

Yesterday, under Today’s Highlights, we posted that the U.S. FDA issued a Complete Response Letter (CRL) …

Gilead Sciences: An FDA Complete Response Letter Will Not Stop This Firm from Rallying

August 19, 2020 0

Gilead Sciences Was Issued a CLR from the FDA for Filgotinib Gilead Sciences (GILD) is in …

A Royal Reception by Investors for CureVac. See Also: Good Oncology News for Bristol-Myers Squibb

August 17, 2020 0

CureVac is Publicy Trading on the NASDAQ CureVac is now publicly trading on the NASDAQ stock …

An Important Announcement from Sorrento Therapeutics

August 13, 2020 0

Sorrento Therapeutics Announcement Sorrento Therapeutics (SRNE) announced that it believes it has uncovered fraudulent attempts to …

Monopar Therapeutics: A Plan for a Test that Predicts COVID-19 Patients Who Might Likely Develop Severe Respiratory Failure

August 13, 2020 0

A Predictive COVID-19 Test? COVID-19 infected people are not all affected to the same degree with …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Sanofi and GlaxoSmithKLine COVID-19 Vaccines are Advancing in Clinical Trial

The U.S. CDC Tells the 50 States to Prepare for COVID-19 Vaccines by the End of October

Agenus: Could It Be a Resurrection? See Also: Prohost Performing Stocks

Moderna Inc Stock is Tanking After Rallying

Why The Time Has Come for Rhythm Pharmaceuticals to Outperform

Moderna Encouraging News. See Also: Translate Bio and Sanofi Good News

Exelixis Announces Submission of sNDA to U.S. FDA for Cabozantinib in Combination with Nivolumab for Advanced RCC

Kazia Therapeutics Product Paxalisib Beats Temozolomide in Overall Survival in Mid-Phase Trial

What’s Going on with Gene Therapy?

The FDA’s Complete Response Letters, Creating Investment Opportunities?

Gilead Sciences: An FDA Complete Response Letter Will Not Stop This Firm from Rallying

A Royal Reception by Investors for CureVac. See Also: Good Oncology News for Bristol-Myers Squibb

An Important Announcement from Sorrento Therapeutics

Monopar Therapeutics: A Plan for a Test that Predicts COVID-19 Patients Who Might Likely Develop Severe Respiratory Failure

Intellia Therapeutics: Realizing the Dream of Curing Devastating Diseases

Seres Therapeutics Oral Microbiome Product SER-109 Meets Trial Endpoint

Alterity Therapeutics: Treating Neurodegenerative Diseases?

Regenxbio: Positive One-Year Data from the Firm’s Gene Therapy RGX-314 for Wet AMD

Compugen: A Stock To Keep

Inovio: Good News About the Firm’s COVID-19 Vaccine’s Capability and Durability